Bio
I am a Research Assistant at Memorial Sloan Kettering studying how inflammatory history, aging, and treatment reshape immune and tissue states over time. My imaging-focused work uses quantitative clinical imaging and radiobiology to extract host phenotypes and relate them to immune, genomic, treatment, and outcome data. I also use single-cell and spatial transcriptomics, bulk RNA, proteomics, and microbiome data to study regulatory and tissue-state dynamics.
I received my M.S. in Bioinformatics from Johns Hopkins University, where I defended StageBridge: Niche-Conditioned Regulatory Transport in Premalignant Epithelial Progression. I modeled how tissue context shapes regulatory state transitions during epithelial progression using spatial and single-nucleus transcriptomics, transcription factor activity, and gene regulatory networks.
Across these problems, I use interpretable deep learning and probabilistic modeling to infer latent biological states from sparse, heterogeneous observations. I am especially interested in biological memory, cell-state transitions, and which computational ideas transfer across modalities, where they break down, and what can be inferred from incomplete data.
Presentations
Selected scientific presentations and accepted conference abstracts.
CT-Based Integrated Body Phenotyping Captures Host Susceptibility to Radiation Pneumonitis in Locally Advanced NSCLC
- Accepted abstract, IASLC World Conference on Lung Cancer, 2026.
CT-Derived Host Immuno-Metabolic Phenotyping Predicts Response to Neoadjuvant Chemoimmunotherapy in Resectable Locally Advanced NSCLC
- Accepted abstract, IASLC World Conference on Lung Cancer, 2026.
CT-Derived Multi-Organ Host Phenotyping of Never-Smoking Women with Lung Cancer
- Accepted abstract, MSK Cancer Engineering Symposium, 2026.
Publications
Peer-reviewed research articles, reviews and correspondence, preprints, current manuscripts, and published meeting abstracts.
Thymic Composition Predicts Radiation Pneumonitis in Locally Advanced NSCLC
Chaunzwa TL, Krishnan G, Book AJ, Miller DG, Amoako-Boadu K, Garomsa B, Meng YJ, Yang E, Ma J, Chidi A, Gomez DR, Shaverdian N.
Journal of Thoracic Oncology. 2026;103949. doi:10.1016/j.jtho.2026.103949.
Critical Role of Keratinocytes and Protease-Activated Receptor 2 in Secondary Lymphedema Development
Park HJ, Pal S, Chen X, Shin J, García Nores GD, Baik JE, Stull-Lane A, Book AJ, Clement CC, Encarnacion EM, Klang MG, Riedel E, Chaunzwa TL, Hespe GE, Santambrogio L, Coriddi M, Dayan JH, Mehrara BJ, Kataru RP.
Clinical and Translational Medicine. 2026;16(6):e70682. doi:10.1002/ctm2.70682.
Cholangiocarcinoma, Sequential Chemotherapy, and Prognostic Tests
Bruckner HW, De Jager R, Knopf E, Bassali F, Book AJ, Gurell D, Nghiem V, Schwartz M, Hirschfeld A.
Frontiers in Oncology. 2024;14:1361420. doi:10.3389/fonc.2024.1361420.
Thymus Composition, Disease Control, and Toxicity in Locally Advanced Lung Cancer
Chaunzwa TL, Book AJ, Garomsa B, Meng YJ, Yang E, Krishnan G, Chidi A, Kim R, Ma J, Riely GJ, Huang J, Simone CB, Shaverdian N, Gomez DR.
medRxiv. 2025. doi:10.1101/2025.10.20.25338395.
Mechanistic Modeling and Machine Learning Identifies Optimum Radiotherapy Schedules to Prevent Treatment-Induced Metastasis
Graser CJ, Zhou Z, Schürch M, Moorhead G, Chaunzwa TL, Book AJ, Dean J, Lin C, Dean JA, Gomez D, Kozono D, Lahav G, Michor F.
bioRxiv. 2025. doi:10.1101/2025.07.02.662373. Manuscript also under review.
CT-Derived Thymic Involution Is Associated with a Peripheral CD8+ Inhibitory-Receptor Phenotype and Inferior Survival in Unresected Locally Advanced NSCLC
Miller DG*, Chaunzwa TL*, Book AJ*, Amoako-Boadu K, Krishnan G, Wu A, Gelblum DY, Okamura YT, Kagami S-I, Rimner A, Deasy JO, Simone CB II, Gomez DR, Chaft JE, Shaverdian N.
Manuscript under review, 2026. *Shared first authorship.
Mechanistic Modeling and Machine Learning Identifies Optimum Radiotherapy Schedules to Prevent Treatment-Induced Metastasis
Graser CJ, Zhou Z, Schürch M, Moorhead G, Chaunzwa TL, Book AJ, Dean J, Lin C, Dean JA, Gomez D, Kozono D, Lahav G, Michor F.
Manuscript under review, 2026. Preprint: bioRxiv doi:10.1101/2025.07.02.662373.
CT-Derived Host Immuno-Metabolic Phenotyping Predicts Response to Neoadjuvant Chemoimmunotherapy in Resectable Locally Advanced NSCLC
Chaunzwa TL*, Yang E*, Book AJ*, Lee V, Krishnan G, Chitsike L, Amoako-Boadu K, Miller D, Xiong K, Meng J, Bott M, Schoenfeld A, Simone CB II, Gomez D, Chaft J, Shaverdian N.
Manuscript in preparation, 2026. *Shared first authorship.